Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-2.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -67.14% |
| Q2 2025 | 6.44% |
| Q1 2025 | 32.28% |
| Q4 2024 | -28.42% |
| Q3 2024 | -1.60% |
| Q2 2024 | 9.70% |
| Q1 2024 | -9.03% |
| Q4 2023 | -0.59% |
| Q3 2023 | 37.33% |
| Q2 2023 | 56.48% |
| Q1 2023 | -15.68% |
| Q4 2022 | -22.11% |
| Q3 2022 | -9.12% |
| Q2 2022 | 39.58% |
| Q1 2022 | 16.96% |
| Q4 2021 | 51.65% |
| Q3 2021 | -24.91% |
| Q2 2021 | 10.47% |
| Q1 2021 | 34.77% |
| Q4 2020 | -3.30% |
| Q3 2020 | 23.38% |
| Q2 2020 | -20.05% |
| Q1 2020 | 0.00% |